InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,176.00
(
-0.20%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.99
(
0.62%
)
Bitcoin
60,853.92
(
0.07%
)
Post# of 964
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 144
Posts 27604
Boards Moderated 3
Alias Born 02/07/2004

midastouch017

Re: rwwine post# 525

Monday, 04/17/2023 2:09:22 PM

Monday, April 17, 2023 2:09:22 PM

Post# of 964
Gamida cell therapy Omisirge for blood cancer patients approved by FDA

Apr. 17, 2023 1:51 PM ET
Gamida Cell Ltd. (GMDA)
By: Jonathan Block, SA News Editor2

The US FDA has approved Omisirge (omidubicel-onlv), an allogeneic blood-based cell therapy from Gamida Cell Ltd. (NASDAQ:GMDA) for patients with blood cancers to be used before umbilical cord blood transplants.
The stock is up 34% in Monday afternoon trading.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up